 Voyager Therapeutics Inc NASDAQ:VYGR shares have jumped on the news that the biotechnology company has entered into a strategic collaboration with Neurocrine Biosciences NASDAQ:NBIX Inc to advance multiple gene therapies for the treatment of neurological diseases. The companys stock was up 15.7 at US8.05 just before noon on Monday, while Neurocrine shares had shed 9.3 to US111.62. 